Study ID: CTSU S1001
Description:
Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)
Location:
Sioux Falls Region,Fargo Region
Principal Investigator:
Miroslaw Mazurczak MD,Preston Steen MD
Disease:
NHL (Non-Hodgkins Lymphoma)
Stage:
Phase II
Status:
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.
Back to Clinical Trials list